The company's financial leverage has deteriorated significantly, with the debt-to-equity ratio ballooning from 5.82 in 2023Q4 to 20.33 in 2026Q1 as equity reserves continue to contract.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Total Current Assets | 2.93B | 3B | 3.03B | 3.83B | 3.21B | 3.35B | 2.63B | 2.78B | 3.29B | 3.49B | 2.55B | 2.3B | 1.96B | 1.98B | 1.83B |
| Cash & Short-Term Investments | 563M | 672M | 713M | 1.2B | 1.1B | 1.45B | 1.1B | 943M | 1.2B | 1.56B | 902M | 366M | 0 | 0 | 0 |
| Cash Only | 563M | 672M | 713M | 1.2B | 1.1B | 1.45B | 1.1B | 943M | 1.2B | 1.56B | 902M | 366M | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 759M | 679M | 770M | 610M | 626M | 720M | 511M | 674M | 861M | 919M | 807M | 859M | 784M | 776M | 742M |
| Days Sales Outstanding | 52.42 | 42.67 | 48.61 | 36.63 | 33.45 | 41.42 | 37.54 | 44.52 | 47.34 | 54.25 | 54.55 | 54.84 | 44.49 | 41.29 | 36.77 |
| Inventory | 1.54B | 1.57B | 1.47B | 1.35B | 1.4B | 1.1B | 939M | 1.08B | 1.15B | 935M | 767M | 972M | 1.05B | 1.05B | 977M |
| Days Inventory Outstanding | 114.64 | 116.73 | 116.02 | 103.41 | 98.27 | 80.81 | 87.84 | 88.24 | 89.71 | 77.05 | 65.26 | 74.5 | 75.71 | 71.38 | 71.12 |
| Other Current Assets | 70M | 81M | 71M | 705M | 82M | 0 | 78M | 0 | 84M | 83M | 77M | 104M | 88M | 109M | 50M |
| Total Non-Current Assets | 4.34B | 4.38B | 4.49B | 4.42B | 4.43B | 4.21B | 4.45B | 4.48B | 4.07B | 3.8B | 3.51B | 4B | 4.02B | 3.64B | 3.48B |
| Property, Plant & Equipment | 3.31B | 3.35B | 3.44B | 3.48B | 3.41B | 3.38B | 3.71B | 3.85B | 3.29B | 3.01B | 2.78B | 3.18B | 3.31B | 2.97B | 2.79B |
| Fixed Asset Turnover | 1.15x | 1.73x | 1.68x | 1.75x | 2.00x | 1.88x | 1.34x | 1.43x | 2.02x | 2.06x | 1.94x | 1.80x | 1.94x | 2.31x | 2.64x |
| Goodwill | 46M | 46M | 46M | 102M | 102M | 102M | 153M | 153M | 153M | 153M | 153M | 166M | 198M | 198M | 198M |
| Intangible Assets | 2M | 2M | 3M | 3M | 13M | 6M | 14M | 21M | 28M | 13M | 17M | 10M | 11M | 17M | 29M |
| Long-Term Investments | 735M | 212M | 152M | 158M | 175M | 169M | 167M | 162M | 160M | 173M | 136M | 136M | 124M | 123M | 130M |
| Other Non-Current Assets | 501M | 772M | 556M | 374M | 573M | 376M | 310M | 252M | 391M | 413M | 376M | 461M | 366M | 322M | 325M |
| Total Assets | 7.27B | 7.38B | 7.51B | 8.25B | 7.64B | 7.55B | 7.08B | 7.26B | 7.36B | 7.29B | 6.06B | 6.3B | 5.98B | 5.62B | 5.32B |
| Asset Turnover | 0.78x | 0.79x | 0.77x | 0.74x | 0.89x | 0.84x | 0.70x | 0.76x | 0.90x | 0.85x | 0.89x | 0.91x | 1.08x | 1.22x | 1.39x |
| Asset Growth % | 1.24% | -1.77% | -8.92% | 8% | 1.19% | 6.61% | -2.42% | -1.41% | 0.95% | 20.35% | -3.78% | 5.35% | 6.35% | 5.72% | - |
| Total Current Liabilities | 1.61B | 1.69B | 1.8B | 2.49B | 1.89B | 1.86B | 1.44B | 1.54B | 1.71B | 1.65B | 1.77B | 1.47B | 1.41B | 1.47B | 1.23B |
| Accounts Payable | 863M | 929M | 1.12B | 1.13B | 1.21B | 1.14B | 820M | 901M | 1.14B | 1.07B | 884M | 945M | 1B | 1.03B | 887M |
| Days Payables Outstanding | 70.04 | 69.12 | 88.27 | 86.74 | 84.69 | 83.9 | 76.7 | 73.69 | 88.92 | 88.59 | 75.21 | 72.43 | 72.25 | 69.41 | 64.57 |
| Short-Term Debt | 99M | 104M | 54M | 51M | 43M | 25M | 21M | 134M | 13M | 15M | 15M | 39M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 12M | 0 | 0 | 0 | 0 | 3M | 7M | 7M | 6M | 8M | 76M | 20M | 38M | 32M | 13M |
| Other Current Liabilities | 506M | 547M | 554M | 1.13B | 325M | 440M | 81M | 148M | 342M | 291M | 572M | 293M | 47M | 109M | 166M |
| Current Ratio | 1.82x | 1.78x | 1.68x | 1.54x | 1.70x | 1.80x | 1.83x | 1.80x | 1.93x | 2.12x | 1.44x | 1.57x | 1.39x | 1.35x | 1.49x |
| Quick Ratio | 0.87x | 0.85x | 0.86x | 1.00x | 0.96x | 1.21x | 1.17x | 1.10x | 1.26x | 1.55x | 1.01x | 0.91x | 0.65x | 0.63x | 0.69x |
| Cash Conversion Cycle | 97.02 | 90.29 | 76.35 | 53.31 | 47.03 | 38.33 | 48.67 | 59.08 | 48.13 | 42.71 | 44.59 | 56.91 | 47.94 | 43.26 | 43.32 |
| Total Non-Current Liabilities | 5.44B | 5.45B | 5.11B | 5.03B | 4.64B | 4.61B | 4.83B | 5.02B | 4.63B | 4.78B | 4.18B | 4.7B | 898M | 871M | 855M |
| Long-Term Debt | 4.07B | 4.26B | 4.02B | 3.94B | 3.59B | 3.72B | 4B | 4.03B | 3.96B | 4.1B | 3.53B | 3.92B | 421M | 420M | 428M |
| Capital Lease Obligations | 847M | 219M | 227M | 252M | 198M | 179M | 194M | 245M | 2M | 3M | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 118M | 37M | 35M | 44M | 61M | 49M | 36M | 118M | 217M | 208M | 132M | 234M | 434M | 415M | 391M |
| Other Non-Current Liabilities | 1.11B | 927M | 824M | 789M | 793M | 656M | 585M | 625M | 448M | 466M | 519M | 542M | 477M | 451M | 36M |
| Total Liabilities | 7.05B | 7.13B | 6.91B | 7.51B | 6.53B | 6.47B | 6.27B | 6.56B | 6.34B | 6.43B | 5.96B | 6.17B | 2.31B | 2.34B | 2.09B |
| Total Debt | 4.39B | 4.58B | 4.36B | 4.3B | 3.88B | 3.99B | 4.28B | 4.47B | 3.97B | 4.11B | 3.54B | 3.95B | 0 | 0 | 0 |
| Net Debt | 3.83B | 3.91B | 3.64B | 3.1B | 2.78B | 2.54B | 3.17B | 3.53B | 2.77B | 2.56B | 2.64B | 3.59B | 0 | 0 | 0 |
| Debt / Equity | 20.33x | 18.27x | 7.20x | 5.82x | 3.50x | 3.68x | 5.25x | 6.43x | 3.89x | 4.75x | 34.08x | 30.42x | - | - | - |
| Debt / EBITDA | -33.27x | 13.69x | 5.85x | 23.36x | 3.60x | 4.02x | 5.57x | 6.25x | 2.62x | 3.06x | 9.33x | 8.02x | - | - | - |
| Net Debt / EBITDA | -29.00x | 11.68x | 4.90x | 16.83x | 2.58x | 2.56x | 4.13x | 4.93x | 1.83x | 1.90x | 6.95x | 7.28x | - | - | - |
| Interest Coverage | 1.15x | -0.03x | 1.48x | -0.53x | 5.55x | 4.65x | 2.13x | 2.15x | 6.46x | 5.24x | 0.95x | 1.71x | - | - | - |
| Total Equity | 216M | 251M | 605M | 739M | 1.11B | 1.08B | 815M | 695M | 1.02B | 865M | 104M | 130M | 3.67B | 3.28B | 3.23B |
| Equity Growth % | -242.78% | -58.51% | -18.13% | -33.24% | 2.31% | 32.76% | 17.27% | -31.86% | 17.92% | 731.73% | -20% | -96.46% | 12.02% | 1.55% | - |
| Book Value per Share | 1.43 | 1.67 | 4.03 | 4.96 | 6.99 | 6.41 | 4.90 | 4.22 | 5.59 | 4.53 | 0.57 | 0.72 | 20.10 | 17.94 | 17.67 |
| Total Shareholders' Equity | 215M | 250M | 604M | 737M | 1.11B | 1.08B | 813M | 689M | 1.01B | 860M | 100M | 126M | 3.67B | 3.28B | 3.23B |
| Common Stock | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 3.65B | 3.19B | 3.21B |
| Retained Earnings | 1.18B | 1.22B | 1.72B | 1.78B | 2.17B | 1.75B | 1.3B | 1.25B | 1.47B | 579M | -114M | -115M | 0 | 0 | 0 |
| Treasury Stock | -1.8B | -1.8B | -1.8B | -1.81B | -1.74B | -1.25B | -1.07B | -1.07B | -750M | -116M | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -244M | -244M | -367M | -274M | -343M | -364M | -310M | -349M | -564M | -442M | -577M | -536M | 19M | 19M | 19M |
| Minority Interest | 1M | 1M | 1M | 2M | 0 | 1M | 2M | 6M | 6M | 5M | 4M | 4M | 4M | 3M | 2M |
Legacy environmental liability overhang
According to the provided quarterly data, the company's equity base has contracted significantly from $737 million in 2023Q4 to $215 million by 2026Q1, signaling a weakening financial position driven by persistent net losses and the ongoing burden of legacy environmental and litigation-related obligations.
The rapid decline in shareholder equity suggests that the firm is struggling to retain earnings, which may limit its ability to fund future growth initiatives. Investors should monitor whether this downward trajectory in equity persists, as it may eventually constrain the company's access to capital markets.
As reported in financial statements, the debt-to-equity ratio has surged from 5.82 in 2023Q4 to 20.33 in 2026Q1, indicating that the company's reliance on debt has intensified significantly relative to its shrinking equity base over the observed ten-quarter period.
This dramatic increase in leverage appears to be a function of both stagnant debt levels and a rapidly eroding equity cushion. Such a high D/E ratio warrants further investigation into the company's debt covenants and its capacity to service interest obligations during cyclical downturns.
Based on the company's reported figures, cash reserves have declined from $1.2 billion in 2023Q4 to $563 million in 2026Q1, while the current ratio has remained relatively tight, fluctuating between 1.54 and 1.89 throughout the same period.
The reduction in cash on hand suggests that the company is consuming its liquidity buffer to manage operational costs and legal settlements. This trend may indicate a narrowing margin of safety for meeting short-term obligations if cash flow generation does not improve.
As evidenced by the provided balance sheet data, the sudden shift in reported PPE from $3.4 billion in 2025Q3 to $10.2 billion in 2025Q4 suggests potential accounting distortions or significant revaluations that may obscure the true underlying quality of the company's manufacturing asset base.
Such a massive, unexplained swing in fixed assets warrants extreme caution, as it may not reflect actual capital investment but rather accounting adjustments. Analysts should scrutinize whether this volatility masks underlying impairment risks or changes in how the company accounts for its specialized chemical facilities.
Quick answers to the most common questions about buying CC stock.
As of 2025, The Chemours Company (CC) had total assets of $7.38B including $3.00B in current assets.
The Chemours Company (CC) carries total debt of $4.58B, offset by $672.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
The Chemours Company (CC) has total shareholders' equity (book value) of $250.0M ($1.67 book value per share). Book value represents the net worth of the company belonging to common stock holders.
The Chemours Company (CC) reported a current ratio of 1.78x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.